Medartis Holding AG
Medartis Holding AG (MDRSF) Revenue
Annual & quarterly revenue history · segment & region breakdown
MDRSF · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsMedartis Holding AG trailing twelve-month (TTM) revenue is $0.49B, an increase of 19.76% year-over-year from $0.27B in FY2025.
Revenue trend
2025 – 2015 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.27B | +$0.04B | +19.76% |
| 2024-12-31 | $0.22B | +$0.01B | +6.05% |
| 2023-12-31 | $0.21B | +$0.03B | +15.96% |
| 2022-12-31 | $0.18B | +$0.02B | +14.35% |
| 2021-12-31 | $0.16B | +$0.03B | +25.25% |
| 2020-12-31 | $0.13B | -$0.00B | -1.92% |
| 2019-12-31 | $0.13B | +$0.01B | +7.27% |
| 2018-12-31 | $0.12B | +$0.02B | +15.50% |
| 2017-12-31 | $0.11B | +$0.01B | +13.55% |
| 2016-12-31 | $0.09B | +$0.01B | +12.39% |
Compare revenue vs peers
Medical - DevicesCompare MDRSF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Medartis Holding AG receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Medartis Holding AG reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CHF.
Data sourced from Medartis Holding AG's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
MDRSF revenue · 4 questionsMDRSF's trailing twelve-month (TTM) revenue is $0.49B. That is an increase of 19.76% year-over-year from $0.27B in FY2025.
▸ Source: FMP · Medartis Holding AG SEC filings · GAAP · Medartis Holding AG SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026